<?xml version="1.0"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:video="http://www.google.com/schemas/sitemap-video/1.1" xmlns:xhtml="http://www.w3.org/1999/xhtml"><url><loc>https://www.gazyva-hcp.com/</loc><lastmod>2025-11-02</lastmod></url><url><loc>https://www.gazyva-hcp.com/lupus-nephritis.html</loc><lastmod>2025-11-07</lastmod></url><url><loc>https://www.gazyva-hcp.com/lupus-nephritis/about-lupus-nephritis.html</loc><lastmod>2025-10-31</lastmod></url><url><loc>https://www.gazyva-hcp.com/lupus-nephritis/how-gazyva-is-thought-to-work.html</loc><lastmod>2025-11-03</lastmod><video:video><video:title>How GAZYVA Is Thought to Work in Lupus Nephritis</video:title><video:description><![CDATA[GAZYVA is a type II, humanized, anti-CD20 monoclonal antibody that targets <span class="nowrap-text">B cells.<sup><span class="reference">1,18,19</span></sup></span>]]></video:description><video:thumbnail_loc>https://cf-images.us-east-1.prod.boltdns.net/v1/static/6125588073001/be52e329-ce0c-48fb-97c0-677e06443b2d/58522edf-631c-41f3-a293-c4124c18504a/231x130/match/image.jpg</video:thumbnail_loc><video:player_loc>https://players.brightcove.net/6125588073001/3cfaAcUC_default/index.html?videoId=6384314652112</video:player_loc><video:duration>1005</video:duration></video:video></url><url><loc>https://www.gazyva-hcp.com/lupus-nephritis/efficacy/study-information.html</loc><lastmod>2025-10-31</lastmod></url><url><loc>https://www.gazyva-hcp.com/lupus-nephritis/efficacy/primary-endpoint.html</loc><lastmod>2025-10-31</lastmod></url><url><loc>https://www.gazyva-hcp.com/lupus-nephritis/efficacy/secondary-endpoints.html</loc><lastmod>2025-11-02</lastmod></url><url><loc>https://www.gazyva-hcp.com/lupus-nephritis/efficacy/exploratory-endpoints.html</loc><lastmod>2025-10-31</lastmod></url><url><loc>https://www.gazyva-hcp.com/lupus-nephritis/efficacy/lupus-nephritis-patient-profiles.html</loc><lastmod>2025-10-31</lastmod></url><url><loc>https://www.gazyva-hcp.com/lupus-nephritis/safety/safety-profile.html</loc><lastmod>2025-10-31</lastmod></url><url><loc>https://www.gazyva-hcp.com/lupus-nephritis/dosing-and-administration/prior-to-administration.html</loc><lastmod>2025-10-31</lastmod></url><url><loc>https://www.gazyva-hcp.com/lupus-nephritis/dosing-and-administration/dosing-schedule-and-infusion-rates.html</loc><lastmod>2025-11-03</lastmod></url><url><loc>https://www.gazyva-hcp.com/lupus-nephritis/dosing-and-administration/irr-management.html</loc><lastmod>2025-10-31</lastmod></url><url><loc>https://www.gazyva-hcp.com/lupus-nephritis/dosing-and-administration/supply-and-storage.html</loc><lastmod>2025-10-31</lastmod></url><url><loc>https://www.gazyva-hcp.com/lupus-nephritis/resources/downloadable-resources.html</loc><lastmod>2025-11-21</lastmod></url><url><loc>https://www.gazyva-hcp.com/lupus-nephritis/resources/clinical-education-managers.html</loc><lastmod>2025-10-31</lastmod></url><url><loc>https://www.gazyva-hcp.com/lupus-nephritis/resources/helpful-resources-for-your-practice.html</loc><lastmod>2025-11-03</lastmod></url><url><loc>https://www.gazyva-hcp.com/lupus-nephritis/resources/practice-forms-and-documents.html</loc><lastmod>2025-10-27</lastmod></url><url><loc>https://www.gazyva-hcp.com/lupus-nephritis/financial-support/assistance-options.html</loc><lastmod>2025-11-03</lastmod></url><url><loc>https://www.gazyva-hcp.com/lupus-nephritis/financial-support/eligibility-and-enrollment.html</loc><lastmod>2025-11-03</lastmod></url><url><loc>https://www.gazyva-hcp.com/lupus-nephritis/financial-support/faqs.html</loc><lastmod>2025-11-03</lastmod></url><url><loc>https://www.gazyva-hcp.com/lupus-nephritis/financial-support/case-managers.html</loc><lastmod>2025-11-05</lastmod></url><url><loc>https://www.gazyva-hcp.com/lupus-nephritis/search.html</loc><lastmod>2025-10-31</lastmod></url><url><loc>https://www.gazyva-hcp.com/cll.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/cll/moa/proposed-moa.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/cll/approved-regimens/fl-and-cll.html</loc><lastmod>2023-02-02</lastmod></url><url><loc>https://www.gazyva-hcp.com/cll/efficacy/trial-information.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/cll/efficacy/clinical-results.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/cll/side-effects-and-safety/side-effects.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/cll/side-effects-and-safety/incidence-of-irr.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/cll/side-effects-and-safety/premedicating-for-irr.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/cll/side-effects-and-safety/making-adjustments-to-infusions.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/cll/side-effects-and-safety/important-safety-information.html</loc><lastmod>2022-11-22</lastmod></url><url><loc>https://www.gazyva-hcp.com/cll/dosing-and-administration/preparation-and-storage.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/cll/dosing-and-administration/gazyva-dosing.html</loc><lastmod>2026-01-15</lastmod></url><url><loc>https://www.gazyva-hcp.com/cll/dosing-and-administration/administering-gazyva.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/cll/resources/printable-resources.html</loc><lastmod>2022-09-21</lastmod></url><url><loc>https://www.gazyva-hcp.com/cll/resources/helpful-links.html</loc><lastmod>2022-09-21</lastmod></url><url><loc>https://www.gazyva-hcp.com/cll/resources/helpful-resources-for-your-practice.html</loc><lastmod>2024-08-14</lastmod></url><url><loc>https://www.gazyva-hcp.com/cll/resources/practice-forms-and-documents.html</loc><lastmod>2023-02-13</lastmod></url><url><loc>https://www.gazyva-hcp.com/cll/financial-support/assistance-options.html</loc><lastmod>2026-01-14</lastmod></url><url><loc>https://www.gazyva-hcp.com/cll/financial-support/eligibility-and-enrollment.html</loc><lastmod>2022-11-30</lastmod></url><url><loc>https://www.gazyva-hcp.com/cll/financial-support/faqs.html</loc><lastmod>2023-01-09</lastmod></url><url><loc>https://www.gazyva-hcp.com/cll/financial-support/case-managers.html</loc><lastmod>2023-07-18</lastmod></url><url><loc>https://www.gazyva-hcp.com/cll/search.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/follicular-lymphoma.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/follicular-lymphoma/about/how-gazyva-works.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/follicular-lymphoma/approved-regimens/fl-and-cll.html</loc><lastmod>2023-01-13</lastmod></url><url><loc>https://www.gazyva-hcp.com/follicular-lymphoma/efficacy/trial-information.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/follicular-lymphoma/efficacy/clinical-results.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/follicular-lymphoma/side-effects-and-safety/possible-side-effects.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/follicular-lymphoma/side-effects-and-safety/incidence-of-irr.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/follicular-lymphoma/side-effects-and-safety/premedicating-for-irr.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/follicular-lymphoma/side-effects-and-safety/making-adjustments-to-infusions.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/follicular-lymphoma/side-effects-and-safety/important-safety-information.html</loc><lastmod>2022-11-22</lastmod></url><url><loc>https://www.gazyva-hcp.com/follicular-lymphoma/dosing-and-administration/preparation-and-storage.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/follicular-lymphoma/dosing-and-administration/gazyva-dosing.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/follicular-lymphoma/dosing-and-administration/administering-gazyva.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/follicular-lymphoma/resources/printable-resources.html</loc><lastmod>2022-09-21</lastmod></url><url><loc>https://www.gazyva-hcp.com/follicular-lymphoma/resources/helpful-links.html</loc><lastmod>2022-09-21</lastmod></url><url><loc>https://www.gazyva-hcp.com/follicular-lymphoma/resources/helpful-resources-for-your-practice.html</loc><lastmod>2024-08-14</lastmod></url><url><loc>https://www.gazyva-hcp.com/follicular-lymphoma/resources/practice-forms-and-documents.html</loc><lastmod>2023-02-13</lastmod></url><url><loc>https://www.gazyva-hcp.com/follicular-lymphoma/financial-support/assistance-options.html</loc><lastmod>2025-01-03</lastmod></url><url><loc>https://www.gazyva-hcp.com/follicular-lymphoma/financial-support/eligibility-and-enrollment.html</loc><lastmod>2022-11-30</lastmod></url><url><loc>https://www.gazyva-hcp.com/follicular-lymphoma/financial-support/faqs.html</loc><lastmod>2023-01-09</lastmod></url><url><loc>https://www.gazyva-hcp.com/follicular-lymphoma/financial-support/case-managers.html</loc><lastmod>2023-07-18</lastmod></url><url><loc>https://www.gazyva-hcp.com/follicular-lymphoma/search.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/rr-follicular-lymphoma.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/rr-follicular-lymphoma/regimens/approved-regimens.html</loc><lastmod>2023-02-02</lastmod></url><url><loc>https://www.gazyva-hcp.com/rr-follicular-lymphoma/efficacy/gadolin-trial.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/rr-follicular-lymphoma/efficacy/clinical-results.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/rr-follicular-lymphoma/safety/possible-side-effects.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/rr-follicular-lymphoma/safety/incidence-of-irr.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/rr-follicular-lymphoma/safety/premedicating-for-irr.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/rr-follicular-lymphoma/safety/making-adjustments-to-infusions.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/rr-follicular-lymphoma/safety/important-safety-information.html</loc><lastmod>2022-11-22</lastmod></url><url><loc>https://www.gazyva-hcp.com/rr-follicular-lymphoma/dosing-and-administration/preparation-and-storage.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/rr-follicular-lymphoma/dosing-and-administration/gazyva-dosing.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/rr-follicular-lymphoma/dosing-and-administration/administering-gazyva.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/rr-follicular-lymphoma/resources/printable-resources.html</loc><lastmod>2022-09-21</lastmod></url><url><loc>https://www.gazyva-hcp.com/rr-follicular-lymphoma/resources/helpful-links.html</loc><lastmod>2022-09-21</lastmod></url><url><loc>https://www.gazyva-hcp.com/rr-follicular-lymphoma/resources/helpful-resources-for-your-practice.html</loc><lastmod>2024-08-14</lastmod></url><url><loc>https://www.gazyva-hcp.com/rr-follicular-lymphoma/resources/practice-forms-and-documents.html</loc><lastmod>2023-02-13</lastmod></url><url><loc>https://www.gazyva-hcp.com/rr-follicular-lymphoma/financial-support/assistance-options.html</loc><lastmod>2025-01-03</lastmod></url><url><loc>https://www.gazyva-hcp.com/rr-follicular-lymphoma/financial-support/eligibility-and-enrollment.html</loc><lastmod>2022-11-30</lastmod></url><url><loc>https://www.gazyva-hcp.com/rr-follicular-lymphoma/financial-support/faqs.html</loc><lastmod>2023-01-09</lastmod></url><url><loc>https://www.gazyva-hcp.com/rr-follicular-lymphoma/financial-support/case-managers.html</loc><lastmod>2023-07-18</lastmod></url><url><loc>https://www.gazyva-hcp.com/rr-follicular-lymphoma/search.html</loc><lastmod>2025-10-17</lastmod></url><url><loc>https://www.gazyva-hcp.com/contact-a-rep.html</loc><lastmod>2025-10-31</lastmod></url><url><loc>https://www.gazyva-hcp.com/safety.html</loc><lastmod>2025-10-31</lastmod></url><url><loc>https://www.gazyva-hcp.com/sitemap.html</loc><lastmod>2025-11-03</lastmod></url></urlset>